BRPI0414678A - forma polimórfica de 3-fenil sulfonil-8-piperazin-1-il quinolina - Google Patents
forma polimórfica de 3-fenil sulfonil-8-piperazin-1-il quinolinaInfo
- Publication number
- BRPI0414678A BRPI0414678A BRPI0414678-6A BRPI0414678A BRPI0414678A BR PI0414678 A BRPI0414678 A BR PI0414678A BR PI0414678 A BRPI0414678 A BR PI0414678A BR PI0414678 A BRPI0414678 A BR PI0414678A
- Authority
- BR
- Brazil
- Prior art keywords
- quinoline
- piperazin
- polymorphic form
- phenyl sulfonyl
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
"FORMA POLIMóRFICA DE 3-FENIL SULFONIL-8PIPERAZIN-1-IL QUINOLINA". Esta invenção refere-se a um novo composto de 3fenil sulfonil-8-piperazin-1-il quinolina, a processos para sua preparação, a composições contendo o mesmo e a seu uso no tratamento de CNS e outras desordens.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0322629.7A GB0322629D0 (en) | 2003-09-26 | 2003-09-26 | Novel compound |
| PCT/EP2004/010843 WO2005040124A1 (en) | 2003-09-26 | 2004-09-23 | A polymorphic form of 3-phenylsulfonyl -8-piperazin-1-yl-quinoline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0414678A true BRPI0414678A (pt) | 2006-11-28 |
Family
ID=29286934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0414678-6A BRPI0414678A (pt) | 2003-09-26 | 2004-09-23 | forma polimórfica de 3-fenil sulfonil-8-piperazin-1-il quinolina |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20070032504A1 (pt) |
| EP (1) | EP1667975B1 (pt) |
| JP (1) | JP2007506702A (pt) |
| CN (1) | CN1856471A (pt) |
| AU (1) | AU2004283805A1 (pt) |
| BR (1) | BRPI0414678A (pt) |
| CA (1) | CA2540022A1 (pt) |
| CO (1) | CO5680402A2 (pt) |
| DE (1) | DE602004010410T2 (pt) |
| DK (1) | DK1667975T3 (pt) |
| ES (1) | ES2297465T3 (pt) |
| GB (1) | GB0322629D0 (pt) |
| HK (1) | HK1094190A1 (pt) |
| HR (1) | HRP20080055T3 (pt) |
| IL (1) | IL174213A0 (pt) |
| IS (1) | IS8399A (pt) |
| MA (1) | MA28093A1 (pt) |
| MX (1) | MXPA06003375A (pt) |
| NO (1) | NO20061791L (pt) |
| PL (1) | PL1667975T3 (pt) |
| PT (1) | PT1667975E (pt) |
| RU (1) | RU2355681C2 (pt) |
| WO (1) | WO2005040124A1 (pt) |
| ZA (1) | ZA200601453B (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04009318A (es) * | 2002-03-27 | 2005-01-25 | Glaxo Group Ltd | Derivados de quinolina y su uso como ligados 5-ht6. |
| DE602004000260T2 (de) | 2003-07-22 | 2006-08-24 | Arena Pharmaceuticals, Inc., San Diego | Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen |
| PT1663958E (pt) | 2003-09-18 | 2015-06-01 | Virobay Inc | Compostos contendo haloalquilo como inibidores de protease de cisteína |
| KR100978954B1 (ko) | 2005-06-02 | 2010-08-30 | 에프. 호프만-라 로슈 아게 | Ｇａｂａ-ｂ 증강인자로서 3-메테인설폰일퀴놀린 |
| GB0519758D0 (en) * | 2005-09-28 | 2005-11-09 | Glaxo Group Ltd | Novel process |
| JP2010521516A (ja) * | 2007-03-21 | 2010-06-24 | グラクソ グループ リミテッド | 疼痛および過敏性腸症候群の治療におけるキノリン誘導体の使用 |
| US9084742B2 (en) | 2007-12-12 | 2015-07-21 | Axovant Sciences Ltd. | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-Quinoline |
| WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| US9126946B2 (en) | 2008-10-28 | 2015-09-08 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto |
| MX2017016413A (es) | 2015-06-12 | 2018-08-01 | Axovant Sciences Gmbh | Derivados de diaril y arilheteroaril urea como moduladores del receptor 5ht2a de serotonina útiles para la profilaxis y el tratamineto de un trastorno conductual del sueño rem. |
| JP2018520187A (ja) | 2015-07-15 | 2018-07-26 | アクソヴァント サイエンシーズ ゲゼルシャフト ミット ベシュレンクテル ハフツングAxovant Sciences GmbH | 神経変性疾患と関連する幻覚の予防および処置のために有用な５−ｈｔ２ａセロトニン受容体のモジュレーターとしてのジアリールおよびアリールヘテロアリール尿素誘導体 |
| CN108290842B (zh) * | 2016-05-27 | 2021-04-06 | 深圳市塔吉瑞生物医药有限公司 | 一种取代的喹啉化合物及其药物组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9818916D0 (en) * | 1998-08-28 | 1998-10-21 | Smithkline Beecham Plc | Use |
| MXPA04009318A (es) * | 2002-03-27 | 2005-01-25 | Glaxo Group Ltd | Derivados de quinolina y su uso como ligados 5-ht6. |
| GB0321473D0 (en) * | 2003-09-12 | 2003-10-15 | Glaxo Group Ltd | Novel compounds |
-
2003
- 2003-09-26 PT PT04765655T patent/PT1667975E/pt unknown
- 2003-09-26 GB GBGB0322629.7A patent/GB0322629D0/en not_active Ceased
-
2004
- 2004-09-23 WO PCT/EP2004/010843 patent/WO2005040124A1/en active IP Right Grant
- 2004-09-23 JP JP2006527373A patent/JP2007506702A/ja not_active Withdrawn
- 2004-09-23 AU AU2004283805A patent/AU2004283805A1/en not_active Abandoned
- 2004-09-23 RU RU2006114024/04A patent/RU2355681C2/ru active
- 2004-09-23 BR BRPI0414678-6A patent/BRPI0414678A/pt not_active IP Right Cessation
- 2004-09-23 PL PL04765655T patent/PL1667975T3/pl unknown
- 2004-09-23 CN CNA2004800275278A patent/CN1856471A/zh active Pending
- 2004-09-23 DK DK04765655T patent/DK1667975T3/da active
- 2004-09-23 EP EP04765655A patent/EP1667975B1/en not_active Expired - Lifetime
- 2004-09-23 CA CA002540022A patent/CA2540022A1/en not_active Abandoned
- 2004-09-23 ES ES04765655T patent/ES2297465T3/es not_active Expired - Lifetime
- 2004-09-23 US US10/572,670 patent/US20070032504A1/en not_active Abandoned
- 2004-09-23 DE DE602004010410T patent/DE602004010410T2/de not_active Expired - Fee Related
- 2004-09-23 MX MXPA06003375A patent/MXPA06003375A/es active IP Right Grant
-
2006
- 2006-02-20 ZA ZA200601453A patent/ZA200601453B/en unknown
- 2006-03-09 IL IL174213A patent/IL174213A0/en unknown
- 2006-03-27 CO CO06030123A patent/CO5680402A2/es not_active Application Discontinuation
- 2006-04-05 IS IS8399A patent/IS8399A/is unknown
- 2006-04-13 MA MA28933A patent/MA28093A1/fr unknown
- 2006-04-24 NO NO20061791A patent/NO20061791L/no not_active Application Discontinuation
- 2006-11-29 HK HK06113097A patent/HK1094190A1/xx not_active IP Right Cessation
-
2008
- 2008-02-04 HR HR20080055T patent/HRP20080055T3/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2006114024A (ru) | 2007-11-10 |
| ES2297465T3 (es) | 2008-05-01 |
| JP2007506702A (ja) | 2007-03-22 |
| RU2355681C2 (ru) | 2009-05-20 |
| IL174213A0 (en) | 2006-08-01 |
| HK1094190A1 (en) | 2007-03-23 |
| ZA200601453B (en) | 2007-04-25 |
| US20070032504A1 (en) | 2007-02-08 |
| AU2004283805A1 (en) | 2005-05-06 |
| GB0322629D0 (en) | 2003-10-29 |
| IS8399A (is) | 2006-04-05 |
| MXPA06003375A (es) | 2006-06-08 |
| MA28093A1 (fr) | 2006-08-01 |
| PT1667975E (pt) | 2008-02-29 |
| EP1667975B1 (en) | 2007-11-28 |
| NO20061791L (no) | 2006-04-24 |
| DE602004010410D1 (en) | 2008-01-10 |
| DE602004010410T2 (de) | 2008-10-16 |
| CO5680402A2 (es) | 2006-09-29 |
| HRP20080055T3 (en) | 2008-02-29 |
| WO2005040124A1 (en) | 2005-05-06 |
| CA2540022A1 (en) | 2005-05-06 |
| CN1856471A (zh) | 2006-11-01 |
| PL1667975T3 (pl) | 2008-04-30 |
| DK1667975T3 (da) | 2008-04-14 |
| EP1667975A1 (en) | 2006-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2014009I2 (no) | Forbindelser, farmasøytiske sammensetninger og anvendelser derav, samt fremgangsmåte for å fremstille nevnte forbindelser | |
| UA81624C2 (ru) | Тризамещённые гетероарилы и способ их получения и применение | |
| TNSN07235A1 (en) | Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride | |
| SE0101675D0 (sv) | Novel composition | |
| AU2002220715A1 (en) | Indolsulfonyl compounds useful in the treatment of cns disorders | |
| MY139566A (en) | Imidazolopyridines and methods of making and using the same | |
| BG108650A (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | |
| NO20062677L (no) | Benzyleteraminforbindelser anvendbare som CCR-5-antagonister | |
| EA200700035A1 (ru) | Сульфаматные и сульфамидные производные для лечения эпилепсии и родственных di sorders | |
| DE60225040D1 (de) | Montelukast-granulatformulierung | |
| PT1347971E (pt) | Inibidores tiazolilicos de tirosina-cinases da familia tec | |
| BR0214705A (pt) | Composição, seu uso, método para prevenção ou tratamento de doença neurodegenerativa, e kit | |
| WO2002060900A3 (en) | Antagonists of mcp-1 function and methods of use thereof | |
| DK1789398T3 (da) | 2-amino-quinazolin derivater anvendelige som inhibitorer af B-sekretase (BACE) | |
| HK1068136A1 (en) | Muscarinic antagonists | |
| TW200621753A (en) | Pyrimidinylimidazoles and methods of making and using the same | |
| TW200724140A (en) | Hydantoin compounds | |
| DE60239218D1 (de) | Synergistische zusammensetzungen für die behandlung von saatgut | |
| GB0111186D0 (en) | Novel compounds | |
| BRPI0414678A (pt) | forma polimórfica de 3-fenil sulfonil-8-piperazin-1-il quinolina | |
| BR0313628A (pt) | Composições lìquidas de limpeza | |
| BRPI0417858A (pt) | composto, composição farmacêutica, e, uso de uma composição farmacêutica | |
| SE9901077D0 (sv) | Novel use | |
| GB0320320D0 (en) | Novel compounds | |
| GB0519760D0 (en) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |